Ignite Creation Date:
2025-12-25 @ 2:55 AM
Ignite Modification Date:
2026-02-21 @ 9:12 AM
Study NCT ID:
NCT00644033
Status:
COMPLETED
Last Update Posted:
2024-01-02
First Post:
2008-03-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual Migraine
Sponsor:
Endo Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
VML 251 00/02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
John C. Campbell, Director, Medical Affairs
Old Organization:
Endo Pharmaceuticals
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |